Tumors Metastatic to Brain Completed Phase 2 Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0029875 (Tumors Metastatic to Brain)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00992602Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast CancerTreatment